Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PYM50028 in mild Alzheimer's disease
NCT00130429Phase 2Completed
- Sponsor
- Phytopharm plc
- Start
- Jan 2004
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of smilagenin in Alzheimer's disease (AD), sponsored by Phytopharm plc. Started Jan 2004; status: completed.
02
Drugs
smilagenin
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00130429.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00130429.